The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors
Open accessPublished version of a preprint
Abstract
Understanding the determinants of adaptive immune response to SARS-CoV-2 is critical for fighting the ongoing COVID-19 pandemic. Here we assayed both antibody and T-cell reactivity to SARS-CoV-2 antigens in COVID-19 convalescent patients and healthy donors sampled before and during the pandemic. Our results show that while anti-SARS-CoV-2 antibodies can distinguish convalescent patients from healthy donors, the magnitude of T-cell response was more pronounced in healthy donors sampled during COVID-19 pandemic than in donors sampled before the outbreak. This hints at the possibility that some individuals have encountered the virus but were protected by T-cell cross-reactivity observed. A public and diverse T-cell response was observed for two A*02-restricted SARS-CoV-2 epitopes, revealing a set of T-cell receptor motifs displaying germline-encoded features. Bulk CD4+ and CD8+ T-cell response to SARS-CoV-2 glycoprotein S is characterized by multiple groups of homologous T-cell receptor sequences some of which are shared across multiple donors, indicating the existence of immunodominant epitopes. Overall, our findings indicate that T cells form an efficient response to SARS-CoV-2 and alongside the antibodies can serve as a useful biomarker for surveying SARS-CoV-2 exposure and immunity. We hope that data, including the set of specific T-cell receptors identified in this study can serve as a basis for future developments of SARS-CoV-2 vaccinations and monitoring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
Antibody responses to SARS-CoV-2 in patients with COVID-19
Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Liao, M., Liu, Y., Yuan, J., Wen, Y., Xu, G., Zhao, J., Cheng, L., Li, J., Wang, X., Wang, F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0901-9 · Cited by 2,614
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788
A serological assay to detect SARS-CoV-2 seroconversion in humans
Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769
Structural and functional analysis of a potent sarbecovirus neutralizing antibody
Pinto, D., Park, Y.-J., Beltramello, M., Walls, A. C., Tortorici, M. A., Bianchi, S., Jaconi, S., Culap, K., Zatta, F., De Marco, A., et al. (2020) · doi:10.1101/2020.04.07.023903 · Cited by 1,752
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Braun, J., Loyal, L., Frentsch, M., Wendisch, D., Georg, P., Kurth, F., Hippenstiel, S., Dingeldey, M., Kruse, B., Fauchere, F., et al. (2020) · Nature · doi:10.1038/s41586-020-2598-9 · Cited by 1,310
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
Mateus, J., Grifoni, A., Tarke, A., Sidney, J., Ramirez, S. I., Dan, J. M., Burger, Z. C., Rawlings, S. A., Smith, D. M., Phillips, E., et al. (2020) · Science · doi:10.1126/science.abd3871 · Cited by 1,120
Weiskopf, D., Schmitz, K. S., Raadsen, M. P., Grifoni, A., Okba, N. M. A., Endeman, H., van den Akker, J. P. C., Molenkamp, R., Koopmans, M. P. G., van Gorp, E. C. M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd2071 · Cited by 907
Research works printed but not linked: 57
- Ahmed, 2020, Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies, Viruses, 12, 254, 10.3390/v12030254 · DOI · Paper page
- Bagaev, 2019, VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium, Nucleic Acids Research, 48, 10.1093/nar/gkz874 · DOI · Paper page
- Bakker, 2008, Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7, Proc. Natl. Acad. Sci. U S A, 105, 3825, 10.1073/pnas.0709717105 · DOI
- Baruah, 2020, Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV, J. Med. Virol., 92, 495, 10.1002/jmv.25698 · DOI · Paper page
- Bovay, 2018, T cell receptor alpha variable 12-2 bias in the immunodominant response to Yellow fever virus, Eur. J. Immunol., 48, 258, 10.1002/eji.201747082 · DOI
- Chen, 2017, Sequence and structural analyses reveal distinct and highly diverse human CD8+ TCR repertoires to immunodominant viral antigens, Cell Rep., 19, 569, 10.1016/j.celrep.2017.03.072 · DOI
- Chen, 2010, Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection, J. Virol., 84, 1289, 10.1128/JVI.01281-09 · DOI · Paper page
- Chen, 2020, Convalescent plasma as a potential therapy for COVID-19, Lancet Infect. Dis., 20, 398, 10.1016/S1473-3099(20)30141-9 · DOI · Paper page
- Culshaw, 2017, Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8+ T cell response, Nat. Immunol., 18, 1228, 10.1038/ni.3850 · DOI
- Danilova, 2018, The mutation-associated neoantigen functional expansion of specific T cells (MANAFEST) assay: a sensitive platform for monitoring antitumor immunity, Cancer Immunol. Res., 6, 888, 10.1158/2326-6066.CIR-18-0129 · DOI · Paper page
- Fan, 2009, Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection, Arch. Virol., 154, 1093, 10.1007/s00705-009-0409-6 · DOI
- Gallais, 2020, Intrafamilial exposure to SARS-CoV-2 induces cellular immune response without seroconversion, medRxiv
- Gangaev, 2020, Profound CD8 T cell responses towards the SARS-CoV-2 ORF1ab in COVID-19 patients, Research Square
- Grifoni, 2020, A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2, Cell Host Microbe, 27, 671, 10.1016/j.chom.2020.03.002 · DOI · Paper page
- Guo, 2020, Profiling early humoral response to diagnose novel coronavirus disease (COVID-19), Clin. Infect. Dis., 71, 778, 10.1093/cid/ciaa310 · DOI · Paper page
- Huang, 2020, A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity, Nat. Commun., 11, 4704, 10.1038/s41467-020-18450-4 · DOI · Paper page
- Ishizuka, 2009, Quantitating T cell cross-reactivity for unrelated peptide antigens, J. Immunol., 183, 4337, 10.4049/jimmunol.0901607 · DOI
- Krammer, 2020, Serology assays to manage COVID-19, Science, 368, 1060, 10.1126/science.abc1227 · DOI · Paper page
- Lee, 2020, In silico identification of vaccine targets for 2019-nCoV, F1000Res., 9, 145, 10.12688/f1000research.22507.2 · DOI
- Li, 2008, T cell responses to whole SARS coronavirus in humans, J. Immunol., 181, 5490, 10.4049/jimmunol.181.8.5490 · DOI · Paper page
- Li, 2004, Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome, J. Infect. Dis., 189, 648, 10.1086/381535 · DOI · Paper page
- Lillie, 2020, Novel coronavirus disease (COVID-19): the first two patients in the UK with person to person transmission, J. Infect., 80, 578, 10.1016/j.jinf.2020.02.020 · DOI · Paper page
- Lv, 2009, Identification of a novel conserved HLA-A∗0201-restricted epitope from the spike protein of SARS-CoV, BMC Immunol., 10, 61, 10.1186/1471-2172-10-61 · DOI
- Miles, 2011, Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infection, J. Immunol., 186, 901, 10.4049/jimmunol.1003167 · DOI
- Minervina, 2020, Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T cell memory formation after mild COVID-19 infection, bioRxiv
- Minervina, 2020, Primary and secondary anti-viral response captured by the dynamics and phenotype of individual T cell clones, eLife, 9, e53704, 10.7554/eLife.53704 · DOI
- Ng, 2016, Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection, Vaccine, 34, 2008, 10.1016/j.vaccine.2016.02.063 · DOI · Paper page
- Nguyen, 2020, Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2, J. Virol., 10.1128/JVI.00510-20 · DOI · Paper page
- Ni, 2020, Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals, Immunity, 52, 971, 10.1016/j.immuni.2020.04.023 · DOI · Paper page
- Nielsen, 2005, The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage, Immunogenetics, 57, 33, 10.1007/s00251-005-0781-7 · DOI · Paper page
- Phan, 2020, In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19, bioRxiv
- Phelan, 2020, The novel coronavirus originating in Wuhan, China: challenges for global health governance, JAMA, 323, 709, 10.1001/jama.2020.1097 · DOI · Paper page
- Pinto, 2020, Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody, Nature, 583, 290, 10.1038/s41586-020-2349-y · DOI · Paper page
- Pogorelyy, 2018, Exploring the pre-immune landscape of antigen-specific T cells, Genome Med., 10, 68, 10.1186/s13073-018-0577-7 · DOI
- Pogorelyy, 2019, A framework for annotation of antigen specificities in high-throughput T-Cell repertoire sequencing studies, Front. Immunol., 10, 2159, 10.3389/fimmu.2019.02159 · DOI
- Price, 2004, T cell receptor recognition motifs govern immune escape patterns in acute SIV infection, Immunity, 21, 793, 10.1016/j.immuni.2004.10.010 · DOI · Paper page
- Reynisson, 2020, NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data, Nucleic Acids Res., 48, W449, 10.1093/nar/gkaa379 · DOI · Paper page
- Ritvo, 2018, High-resolution repertoire analysis reveals a major bystander activation of Tfh and Tfr cells, Proc. Natl. Acad. Sci. U S A, 115, 9604, 10.1073/pnas.1808594115 · DOI
- Rodenko, 2006, Generation of peptide-MHC class I complexes through UV-mediated ligand exchange, Nat. Protoc., 1, 1120, 10.1038/nprot.2006.121 · DOI · Paper page
- Rogers, 2020, Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model, Science, 369, 956, 10.1126/science.abc7520 · DOI · Paper page
- Romero-López, 2020, Prediction of SARS-CoV2 spike protein epitopes reveals HLA-associated susceptibility, Research Square
- Rubelt, 2017, Adaptive Immune Receptor Repertoire Community recommendations for sharing immune-repertoire sequencing data, Nat. Immunol., 18, 1274, 10.1038/ni.3873 · DOI · Paper page
- Schultheiß, 2020, Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease, Immunity, 53, 442, 10.1016/j.immuni.2020.06.024 · DOI · Paper page
- Shanmugaraj, 2020, Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19), Asian Pac. J. Allergy Immunol., 38, 10
- Thevarajan, 2020, Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19, Nat. Med., 26, 453, 10.1038/s41591-020-0819-2 · DOI · Paper page
- Wang, 2004, Identification of an HLA-A∗0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein, Blood, 104, 200, 10.1182/blood-2003-11-4072 · DOI
- Wang, 2020, A human monoclonal antibody blocking SARS-CoV-2 infection, Nat. Commun., 11, 2251, 10.1038/s41467-020-16256-y · DOI · Paper page
- Wang, 2004, T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS, J. Virol., 78, 5612, 10.1128/JVI.78.11.5612-5618.2004 · DOI
- Wong, 2003, Treatment of severe acute respiratory syndrome with convalescent plasma, Hong Kong Med. J., 9, 199
- Wu, 2020, Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications, medRxiv
- Yang, 2007, Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen, J. Gen. Virol., 88, 2740, 10.1099/vir.0.82839-0 · DOI
- Yang, 2006, Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients, Clin. Immunol., 120, 171, 10.1016/j.clim.2006.05.002 · DOI
- Zheng, 2020, Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients, Cell. Mol. Immunol., 17, 541, 10.1038/s41423-020-0401-3 · DOI · Paper page
- Zhou, 2006, Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes, J. Immunol., 177, 2138, 10.4049/jimmunol.177.4.2138 · DOI
- Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 · DOI · Paper page
- Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N. Engl. J. Med., 382, 727, 10.1056/NEJMoa2001017 · DOI · Paper page
- Zvyagin, 2017, Tracking T-cell immune reconstitution after TCRαβ/CD19-depleted hematopoietic cells transplantation in children, Leukemia, 31, 1145, 10.1038/leu.2016.321 · DOI
Cited by
Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., Dejnirattisai, W., Rostron, T., Supasa, P., Liu, C., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0782-6 · Cited by 1,179
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
Sahin, U., Muik, A., Vogler, I., Derhovanessian, E., Kranz, L. M., Vormehr, M., Quandt, J., Bidmon, N., Ulges, A., Baum, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03653-6 · Cited by 919
SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19
Grifoni, A., Sidney, J., Vita, R., Peters, B., Crotty, S., Weiskopf, D., & Sette, A. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.05.010 · Cited by 314
Mudd, P. A., Minervina, A. A., Pogorelyy, M. V., Turner, J. S., Kim, W., Kalaidina, E., Petersen, J., Schmitz, A. J., Lei, T., Haile, A., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.026 · Cited by 309
Immunological memory to SARS‐CoV‐2 infection and COVID‐19 vaccines
Sette, A., & Crotty, S. (2022) · Immunological Reviews · doi:10.1111/imr.13089 · Cited by 269
Metadata
- Authors
- Shomuradova, A. S., Vagida, M. S., Sheetikov, S. A., Zornikova, K. V., Kiryukhin, D., Titov, A., Peshkova, I. O., Khmelevskaya, A., Dianov, D. V., Malasheva, M., Shmelev, A., Serdyuk, Y., Bagaev, D. V., Pivnyuk, A., Shcherbinin, D. S., Maleeva, A. V., Shakirova, N. T., Pilunov, A., Malko, D. B., Khamaganova, E. G., Biderman, B., Ivanov, A., Shugay, M., & Efimov, G. A.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 53
- Issue
- 6
- Pages
- 1245-1257.e5
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W3103140952
- Cited by
- 233
- References
- 16
- FWCI
- 5.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 379 d)
- Funders
- Russian Science Foundation (20-15-00395)
- Russian Foundation for Basic Research (19-34-70011, 075-15-2019-1660)
- Ministry of Science and Higher Education of the Russian Federation (075-15-2019-1789)
- Ministry of Education and Science of the Russian Federation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors. https://app.cochat.ai/papers/10.1016/j.immuni.2020.11.004
- The paper
- Shomuradova, A. S., Vagida, M. S., Sheetikov, S. A., Zornikova, K. V., Kiryukhin, D., Titov, A., Peshkova, I. O., Khmelevskaya, A., Dianov, D. V., Malasheva, M., Shmelev, A., Serdyuk, Y., Bagaev, D. V., Pivnyuk, A., Shcherbinin, D. S., Maleeva, A. V., Shakirova, N. T., Pilunov, A., Malko, D. B., . . . Efimov, G. A. (2020). SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors. Immunity. https://doi.org/10.1016/j.immuni.2020.11.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.